Navigation Links
Allied Healthcare Products Reports Loss On Depressed Sales
Date:5/10/2013

ST. LOUIS, May 10, 2013 /PRNewswire/ -- The continuing recession in domestic hospital equipment and a dip in international sales resulted in a loss for Allied Healthcare Products (NASDAQ: AHPI) in its third quarter of fiscal year 2013.

Net loss for the quarter ending March 31, 2013, was about $280,000, or a negative 3 cents per basic and diluted share, versus a loss of about $146,000, or a negative 2 cents per basic and diluted share, for the prior year. Sales for the third quarter fell from about $10.7 million to about $9.2 million, or almost 14 percent, from the previous year.

For the first three quarters of fiscal 2013, Allied's net loss was $1,158,800 or a negative 14 cents per basic and diluted share, compared to a loss of about $268,000, or negative 3 cents per basic and diluted share, for the prior year. Sales for the company's first three quarters declined from about $32.8 million to $28.4 million, or about 13 percent, from the previous year.

Formerly healthy international sales flattened in the quarter. A major impact was the lack of sales in Venezuela following the illness and death of President Hugo Chavez .

The company is beginning to see good growth in sales with its new carbon dioxide absorbent Litholyme®, used in anesthesia procedures, according to Earl Refsland , Allied president and chief executive officer. "As the market becomes aware of the product's economic and safety benefits, we believe sales will accelerate accordingly," Refsland said.

In a one-time event, Allied booked about $516,000 in income in January 2013 from the demutualization and sale of its product liability insurer.

In what will be a recurring expense, Allied paid a new excise tax on medical devices levied as part of the Affordable Care Act. The tax is 2.3 percent on certain devices and cost Allied $70,000 in the third quarter.

Allied Healthcare Products manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care settings including sub-acute facilities, home healthcare and emergency medical care. Allied product lines include respiratory care products, medical gas equipment and emergency medical products. Allied products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical product dealers.

"SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements."  Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.

 ALLIED HEALTHCARE PRODUCTS, INC.STATEMENT OF OPERATIONS(UNAUDITED)Three months ended,Nine months ended,March 31,March 31,2013201220132012Net sales

$9,210,369$10,702,421$28,418,882$32,778,824Cost of sales

7,530,8168,377,30722,654,42125,312,756Gross profit

1,679,5532,325,1145,764,4617,466,068Selling General and administrative expenses

2,639,9762,555,6498,135,6167,883,631Income (loss) from operations

(960,423)(230,535)(2,371,155)(417,563)Interest income

(2,500)(5,692)(9,547)(21,984)Interest expense

---336Other, net

(507,792)10,297(492,566)36,446(510,292)4,605(502,113)14,798Income (loss) before provision for(benefit from) income taxes

(450,131)(235,140)(1,869,042)(432,361)Provision for (benefit from) income taxes

(171,050)(89,353)(710,236)(164,297)Net income (loss)

($279,081)($145,787)($1,158,806)($268,064)Net income (loss) per share - Basic 

($0.03)($0.02)($0.14)($0.03)Net income (loss) per share - Diluted

($0.03)($0.02)($0.14)($0.03)Weighted average common shares outstanding - Basic

8,029,0768,124,3868,085,0918,124,386Weighted average common shares outstanding - Diluted

8,029,0768,124,3868,085,0918,124,386 ALLIED HEALTHCARE PRODUCTS, INC.BALANCE SHEET(UNAUDITED)March 31, 2013June 30, 2012ASSETSCurrent assets:Cash and cash equivalents

$
4,327,408$
5,284,543Accounts receivable, net of allowances  of $300,000

3,434,7144,843,593Inventories, net

9,725,28410,001,226Income tax receivable

-46,042Other current assets

500,360400,677Total current assets

17,987,76620,576,081Property, plant and equipment, net

9,552,0159,603,556Deferred income taxes

1,611,490867,422Other assets, net

256,599300,010Total assets

$
29,407,870$
31,347,069LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$
,313,073$
,797,144Other accrued liabilities

1,903,3781,855,579Deferred income taxes

789,668802,961Deferred revenue

-114,700Total current liabilities

4,006,1194,570,384Commitments and contingenciesStockholders' equity:Preferred stock; $0.01 par value; 1,500,000 shares

--  authorized; no shares issued and outstandingSeries A preferred stock; $0.01 par value; 200,000 shares

--  authorized; no shares issued and outstandingCommon stock; $0.01 par value; 30,000,000 shares  authorized; 10,427,878 shares issued at March 31,   2013 and June 30, 2012; 8,027,147 and 8,124,386 shares  outstanding at March 31, 2013 and June 30, 2012, respectively

104,279104,279Additional paid-in capital

48,574,03448,540,802Accumulated deficit

(2,295,774)(1,136,968)Less treasury stock, at cost; 2,400,731 and 2,303,492 shares atMarch 31, 2013 and June 30, 2012

(20,980,788)(20,731,428)Total stockholders' equity

25,401,75126,776,685Total liabilities and stockholders' equity

$
29,407,870$
31,347,069


'/>"/>
SOURCE Allied Healthcare Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Allied Healthcare Products Reports Second Quarter Loss
2. Allied Healthcare Reports First Quarter Loss
3. Allied Healthcare Products Reports Loss on Sales Decline
4. BidMed Awarded Equipment Liquidation and Related Services Agreement with the Premier Healthcare Alliance
5. Millennium HealthCare Signs Exclusive Distribution Agreement with Heart Smart Inc.
6. Cynosure to Present at UBS Global Healthcare Conference
7. Smart Water Leadership Summit Focused On Waterborne Disease Prevention in Healthcare Facilities To Be Held In Chicago June 6 & 7
8. Millennium HealthCare Signs Distribution Agreement with Atossa Genetics
9. Change Healthcares Clayton Nicholas to Speak on "Game Mechanics and Other Game Changers in Benefits Education" at IHC Forum East
10. Medifirst Solutions, Inc. Announces New Healthcare And Wellness Division
11. XBiotech to Present at UBS Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017 EU5 Glucose Monitoring Market ... report, "EU5 Glucose Monitoring Market Outlook to 2022", provides ... The report provides value, in millions of US dollars, ... segments - Blood Glucose Meters, Blood Glucose Test Strips ... and distribution shares data for each of these market ...
(Date:1/17/2017)... Jan. 17, 2017 Paragon Bioservices received a ... development services for a variety of National ... medical product development activities. The IDIQ mechanism will ... for task order awards up to $159 million. ... manufacturing and process development of biopharmaceuticals, is one ...
(Date:1/17/2017)... 2017  Pennsylvania Secretary of Health Dr. ... marijuana growers/processors and dispensaries are now available on ... Permit applications will be accepted from February 20 ... an important step forward in getting this valuable ... Murphy said. "We,ve developed a thorough application that ...
Breaking Medicine Technology:
(Date:1/17/2017)... Lehi, Utah (PRWEB) , ... January 17, 2017 ... ... provider of accredited, online continuing education for EMS and firefighting professionals, has released ... Training (VILT) Solution. These new courses are taught live in an online classroom ...
(Date:1/17/2017)... TEXAS (PRWEB) , ... January 17, 2017 , ... ... provider, today announced its partnership with Sigfox in the U.S.A. to ... cities nationwide including new offerings on large-scale environmental sensor deployments such as ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare company focused ... study for its dental gel that shows significant reduction in plaque levels and gum ... The study was conducted at the Beckman Laser Institute at UC Irvine and has ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... private companies and ranked among the top US security companies for consecutive years, ... This announcement brings a year-long independent board nomination process to a close ...
(Date:1/16/2017)... ... January 17, 2017 , ... ... an internationally recognized leader in the fast-casual category, announces a hearty and wholesome ... Good Egg Breakfast Sandwich, Turkey Mash-Up Sandwich, Cranberry Crunch & Honey Parfait, Slow ...
Breaking Medicine News(10 mins):